Antioxidant strategies for Alzheimer's disease (Q34754383)

4 August 2017

1 reference

title

Antioxidant strategies for Alzheimer's disease (English)

1 reference

4 August 2017

0 references

Michael Grundman

1

1 reference

PubMed ID

12133201

4 August 2017

Michael Grundman

series ordinal

2

1 reference

PubMed ID

12133201

4 August 2017

Patrick Delaney

series ordinal

3

1 reference

4 August 2017

1 May 2002

1 reference

Proceedings of the Nutrition Society

4 August 2017

1 reference

4 August 2017

61

1 reference

4 August 2017

2

1 reference

4 August 2017

191-202

1 reference

A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. The Alzheimer's Disease Cooperative Study.

4 August 2017

1 reference

https://api.crossref.org/works/10.1079%2FPNS2002146

Elemental imbalances in the olfactory pathway in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FPNS2002146

Redox-active iron mediates amyloid-beta toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FPNS2002146

Oxidative stress, antioxidants, and Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FPNS2002146

APOE genotype, plasma lipids, lipoproteins, and AD in community elderly.

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FPNS2002146

Patients with Alzheimer's disease have reduced activities in midlife compared with healthy control-group members

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FPNS2002146

Hypercholesterolemia accelerates the Alzheimer's amyloid pathology in a transgenic mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FPNS2002146

Inflammatory markers in younger vs elderly normal volunteers and in patients with Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FPNS2002146

Oxidative injury in diseases of the central nervous system: focus on Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FPNS2002146

Protection against amyloid beta peptide toxicity by zinc.

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FPNS2002146

Increased DNA oxidation and decreased levels of repair products in Alzheimer's disease ventricular CSF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FPNS2002146

Elevated thiobarbituric acid-reactive substances and antioxidant enzyme activity in the brain in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FPNS2002146

Pycnogenol protects vascular endothelial cells from beta-amyloid-induced injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FPNS2002146

A 26-week analysis of a double-blind, placebo-controlled trial of the ginkgo biloba extract EGb 761 in dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FPNS2002146

Low serum docosahexaenoic acid is a significant risk factor for Alzheimer's dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FPNS2002146

Curcuminoids from Curcuma longa L. (Zingiberaceae) that protect PC12 rat pheochromocytoma and normal human umbilical vein endothelial cells from betaA(1-42) insult

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FPNS2002146

Nicotinic receptor stimulation protects neurons against beta-amyloid toxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FPNS2002146

More hippocampal neurons in adult mice living in an enriched environment

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FPNS2002146

Dietary fat intake and the risk of incident dementia in the Rotterdam Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FPNS2002146

Statins and the risk of dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FPNS2002146

Lipid peroxidation and free radical scavengers in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FPNS2002146

Dietary antioxidants and cognitive function in a population-based sample of older persons. The Rotterdam Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FPNS2002146

Exercise and the brain: angiogenesis in the adult rat cerebellum after vigorous physical activity and motor skill learning

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FPNS2002146

Antioxidative effects of docosahexaenoic acid in the cerebrum versus cerebellum and brainstem of aged hypercholesterolemic rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FPNS2002146

Idebenone protects hippocampal neurons against amyloid beta-peptide-induced neurotoxicity in rat primary cultures.

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FPNS2002146

Alpha-lipoic acid as a new treatment option for Alzheimer [corrected] type dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FPNS2002146

Altered glycosylation pattern of proteins in Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FPNS2002146

Treatment of Alzheimer's disease: rationale and strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FPNS2002146

Serum zinc, copper, insulin and lipids in Alzheimer's disease epsilon 4 apolipoprotein E allele carriers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FPNS2002146

IL-1 and anti-inflammatory drugs modulate A beta cytotoxicity in PC12 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FPNS2002146

Copper, iron, and zinc imbalances in severely degenerated brain regions in Alzheimer's disease: possible relation to oxidative stress.

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FPNS2002146

Potent neuroprotective properties against the Alzheimer beta-amyloid by an endogenous melatonin-related indole structure, indole-3-propionic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FPNS2002146

Comparative studies of huperzine A, E2020, and tacrine on behavior and cholinesterase activities.

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FPNS2002146

Rapid induction of Alzheimer A beta amyloid formation by zinc.

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FPNS2002146

Vascular risk factors for Alzheimer's disease: an epidemiologic perspective.

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FPNS2002146

Antioxidant defences and oxidative stress markers in erythrocytes and plasma from normally nourished elderly Alzheimer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FPNS2002146

Learning causes synaptogenesis, whereas motor activity causes angiogenesis, in cerebellar cortex of adult rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FPNS2002146

Cognitive decline is associated with systemic oxidative stress: the EVA study. Etude du Vieillissement Artériel.

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FPNS2002146

A systematic review of vinpocetine therapy in acute ischaemic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FPNS2002146

Hydrogen peroxide mediates amyloid beta protein toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FPNS2002146

Vitamin E protects nerve cells from amyloid beta protein toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FPNS2002146

Neuroprotective abilities of resveratrol and other red wine constituents against nitric oxide-related toxicity in cultured hippocampal neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FPNS2002146

The Ginkgo biloba extract (EGb 761) protects and rescues hippocampal cells against nitric oxide-induced toxicity: involvement of its flavonoid constituents and protein kinase C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FPNS2002146

Dehydroepiandrosterone (DHEA) protects hippocampal cells from oxidative stress-induced damage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FPNS2002146

The Ginkgo biloba extract (EGb 761) protects hippocampal neurons against cell death induced by beta-amyloid.

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FPNS2002146

A double-blind placebo controlled evaluation of the safety and efficacy of vinpocetine in the treatment of patients with chronic vascular senile cerebral dysfunction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FPNS2002146

N-acetylserotonin, melatonin and their derivatives improve cognition and protect against beta-amyloid-induced neurotoxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FPNS2002146

Alzheimer's and Parkinson's disease. Brain levels of glutathione, glutathione disulfide, and vitamin E.

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FPNS2002146

Plasma concentrations of vitamins A and E and carotenoids in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FPNS2002146

Alzheimer's amyloid beta-peptide associated free radicals increase rat embryonic neuronal polyamine uptake and ornithine decarboxylase activity: protective effect of vitamin E.

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FPNS2002146

The Ginkgo biloba extract EGb 761 rescues the PC12 neuronal cells from beta-amyloid-induced cell death by inhibiting the formation of beta-amyloid-derived diffusible neurotoxic ligands.

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FPNS2002146

Glycated tau protein in Alzheimer disease: a mechanism for induction of oxidant stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FPNS2002146

Protection against beta-amyloid peptide toxicity in vivo with long-term administration of ferulic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FPNS2002146

Ascorbic acid prevents beta-amyloid-induced intracellular calcium increase and cell death in PC12 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FPNS2002146

The memory enhancing effects of a Ginkgo biloba/Panax ginseng combination in healthy middle-aged volunteers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FPNS2002146

beta-amyloid peptide-induced death of PC 12 cells and cerebellar granule cell neurons is inhibited by long-term lithium treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FPNS2002146

Plasma chain-breaking antioxidants in Alzheimer's disease, vascular dementia and Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FPNS2002146

Cohort study of vitamin C intake and cognitive impairment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FPNS2002146

Neuroprotection by the metabolic antioxidant alpha-lipoic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FPNS2002146

Advanced glycation end products contribute to amyloidosis in Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FPNS2002146

The safety and lack of efficacy of vinpocetine in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FPNS2002146

A 1-year controlled trial of acetyl-l-carnitine in early-onset AD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FPNS2002146

Tacrine and donepezil attenuate the neurotoxic effect of A beta(25-35) in rat PC12 cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FPNS2002146

Histochemically-reactive zinc in amyloid plaques, angiopathy, and degenerating neurons of Alzheimer's diseased brains

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FPNS2002146

The free radical antioxidant vitamin E protects cortical synaptosomal membranes from amyloid beta-peptide(25-35) toxicity but not from hydroxynonenal toxicity: relevance to the free radical hypothesis of Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FPNS2002146

Psychopharmacological effects of vinpocetine in normal healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FPNS2002146

N-acetyl-L-cysteine protects SHSY5Y neuroblastoma cells from oxidative stress and cell cytotoxicity: effects on beta-amyloid secretion and tau phosphorylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FPNS2002146

The efficacy of Ginkgo biloba on cognitive function in Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FPNS2002146

F4-isoprostanes as specific marker of docosahexaenoic acid peroxidation in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FPNS2002146

Serum total cholesterol, apolipoprotein E epsilon 4 allele, and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FPNS2002146

Increased levels of DNA breaks in cerebral cortex of Alzheimer's disease patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FPNS2002146

Reversal of scopolamine-induced deficits in radial maze performance by (-)-huperzine A: comparison with E2020 and tacrine

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FPNS2002146

Regional membrane phospholipid alterations in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FPNS2002146

In vivo brain concentrations of N-acetyl compounds, creatine, and choline in Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FPNS2002146

The relation between antioxidants and memory performance in the old and very old.

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FPNS2002146

Association of antioxidants with memory in a multiethnic elderly sample using the Third National Health and Nutrition Examination Survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FPNS2002146

Fatty acid composition of brain phospholipids in aging and in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FPNS2002146

Lipid composition in different regions of the brain in Alzheimer's disease/senile dementia of Alzheimer's type

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FPNS2002146

Oxidative stress in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FPNS2002146

Oxidative damage in Alzheimer's.

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FPNS2002146

Plasma antioxidants and cognitive performance in middle-aged and older adults: results of the Austrian Stroke Prevention Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FPNS2002146

Increased lipoprotein oxidation in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FPNS2002146

Effect of zinc ions on the cytotoxicity induced by the amyloid beta-peptide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FPNS2002146

Oxidative stress induces intracellular accumulation of amyloid beta-protein (Abeta) in human neuroblastoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FPNS2002146

Vitamin E concentrations in human brain of patients with Alzheimer's disease, fetuses with Down's syndrome, centenarians, and controls

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FPNS2002146

Cerebrospinal fluid levels of selenium in patients with Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FPNS2002146

Association of vitamin E and C supplement use with cognitive function and dementia in elderly men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FPNS2002146

Four-hydroxynonenal, a product of lipid peroxidation, is increased in the brain in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FPNS2002146

Basic FGF attenuates amyloid beta-peptide-induced oxidative stress, mitochondrial dysfunction, and impairment of Na+/K+-ATPase activity in hippocampal neurons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FPNS2002146

Increased peroxidation and reduced antioxidant enzyme activity in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FPNS2002146

Oxidative damage to mitochondrial DNA is increased in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FPNS2002146

Protective Effect of the Energy Precursor Creatine Against Toxicity of Glutamate and β-Amyloid in Rat Hippocampal Neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FPNS2002146

Protective effects of huperzine A on β-amyloid25–35 induced oxidative injury in rat pheochromocytoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FPNS2002146

21 January 2018

Identifiers

DOI

10.1079/PNS2002146

1 reference

4 August 2017

1 reference

PubMed ID

12133201